loading

Terns Pharmaceuticals Inc Stock (TERN) Latest News

pulisher
Feb 06, 2025

Terns Pharmaceuticals announces CFO transition and consulting agreement - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

Terns Pharmaceuticals announces CFO transition and consulting agreement By Investing.com - Investing.com UK

Feb 06, 2025
pulisher
Feb 06, 2025

Terns Pharmaceuticals CFO Resignation and Leadership Transition - TipRanks

Feb 06, 2025
pulisher
Feb 06, 2025

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Feb 06, 2025
pulisher
Feb 05, 2025

BlackRock, Inc. Increases Stake in Terns Pharmaceuticals Inc - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Oncology & Obesity Pipeline Update: Terns Pharmaceuticals Takes Center Stage at Major Healthcare Conference - StockTitan

Feb 05, 2025
pulisher
Feb 04, 2025

Trading Day Review: Terns Pharmaceuticals Inc (TERN) Loses Momentum, Closing at 4.37 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Is Terns Pharmaceuticals Inc (TERN) positioned for future growth? - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

TERN stock rated an Outperform by Oppenheimer - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Melita Sun Jung Acquires 2,250 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Feb 03, 2025
pulisher
Feb 03, 2025

Executive Compensation Alert: Terns Pharma Grants Quarter-Million Share Options Package - StockTitan

Feb 03, 2025
pulisher
Jan 30, 2025

Terns Pharmaceuticals stock hits 52-week low at $4.32 By Investing.com - Investing.com Australia

Jan 30, 2025
pulisher
Jan 30, 2025

Terns Pharmaceuticals stock hits 52-week low at $4.32 - MSN

Jan 30, 2025
pulisher
Jan 22, 2025

Oppenheimer maintains Terns stock Outperform rating, $20 target - MSN

Jan 22, 2025
pulisher
Jan 16, 2025

As wheel Terns in CML, Novartis’ Scemblix in crosshairs - BioWorld Online

Jan 16, 2025
pulisher
Jan 09, 2025

Objective long/short (TERN) Report - Stock Traders Daily

Jan 09, 2025
pulisher
Jan 09, 2025

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 09, 2025
pulisher
Jan 08, 2025

Terns Pharmaceuticals to Present at J.P. Morgan Healthcare ConferenceKey Updates Expected - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

Terns Pharmaceuticals' chief medical officer sells $25,607 in stock By Investing.com - Investing.com Nigeria

Jan 07, 2025
pulisher
Jan 06, 2025

Jill M. Quigley Sells 6,240 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Insider Emil Kuriakose Sells 4,481 Shares - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Director Jill M. Quigley Sells 8,760 Shares - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) CFO Mark J. Vignola Sells 8,129 Shares - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Mark J. Vignola Sells 9,059 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Terns Pharmaceuticals CFO Mark J. Vignola sells $99,022 in stock By Investing.com - Investing.com Nigeria

Jan 06, 2025
pulisher
Jan 06, 2025

Terns Pharmaceuticals CFO Mark J. Vignola sells $99,022 in stock - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

Terns Pharmaceuticals' chief medical officer sells $25,607 in stock - Investing.com

Jan 06, 2025
pulisher
Jan 02, 2025

Exciting Hire at Terns Pharma! New Employee Receives Special Stock Grant! - Jomfruland.net

Jan 02, 2025
pulisher
Jan 02, 2025

Terns Pharmaceuticals Awards New Employee Stock Options at $5.54 Per Share - StockTitan

Jan 02, 2025
pulisher
Jan 02, 2025

Geode Capital Management LLC Grows Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Jan 02, 2025
pulisher
Dec 27, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Sold by State Street Corp - Defense World

Dec 27, 2024
pulisher
Dec 18, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Trading Down 4.7%Should You Sell? - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Terns Pharmaceuticals' SWOT analysis: promising pipeline drives stock potential - Investing.com

Dec 17, 2024
pulisher
Dec 16, 2024

Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey

Dec 16, 2024
pulisher
Dec 15, 2024

The Manufacturers Life Insurance Company Has $551,000 Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Dec 15, 2024
pulisher
Dec 12, 2024

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stake Reduced by Fmr LLC - MarketBeat

Dec 12, 2024
pulisher
Dec 11, 2024

Insider Spends US$110k Buying More Shares In Terns Pharmaceuticals - Simply Wall St

Dec 11, 2024
pulisher
Dec 11, 2024

Terns Pharmaceuticals CEO & Director Acquires 423% More Stock - Yahoo Finance

Dec 11, 2024
pulisher
Dec 11, 2024

Terns Pharmaceuticals (NASDAQ:TERN) Shares Gap Up Following Insider Buying Activity - Defense World

Dec 11, 2024
pulisher
Dec 10, 2024

Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock - Investing.com India

Dec 10, 2024
pulisher
Dec 09, 2024

Terns pharmaceuticals CEO Amy Burroughs acquires $110,467 in stock By Investing.com - Investing.com Canada

Dec 09, 2024
pulisher
Dec 08, 2024

17,369 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Bought by Intech Investment Management LLC - Defense World

Dec 08, 2024
pulisher
Dec 06, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones By Investing.com - Investing.com South Africa

Dec 06, 2024
pulisher
Dec 05, 2024

Terns Pharmaceuticals' SWOT analysis: stock poised for growth amid clinical milestones - Investing.com

Dec 05, 2024
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):